Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complement and myasthenia gravis
Nicholas Sanderson
Molecular Immunology (2022) Vol. 151, pp. 11-18
Open Access | Times Cited: 13

Showing 13 citing articles:

The complement system in neurodegenerative and inflammatory diseases of the central nervous system
Luciana Negro-Demontel, Adam F. Maleki, Daniel S. Reich, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 7
Ravulizumab in myasthenic crisis: the first case report
Franz Felix Konen, Konstantin Fritz Jendretzky, Dominica Ratuszny, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2898-2901
Open Access | Times Cited: 6
JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway
Yaru Lu, Qian Ma, Lu Yu, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109693-109693
Closed Access | Times Cited: 15
Complement system activation: bridging physiology, pathophysiology, and therapy
Élie Azoulay, Julien Zuber, Ahmed Aziz Bousfiha, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 11, pp. 1791-1803
Closed Access | Times Cited: 5
Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
Lijun Luo, Xinyi Zhu, Chunbei Wen, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
New pathogenic treatments for myasthenia gravis
Т. М. Алексеева, P. Sh. Isabekova, E.I. Kondratova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2025) Vol. 125, Iss. 1, pp. 31-31
Closed Access
Zilucoplan: A Newly Approved Macrocyclic Peptide for Treatment of Anti-Acetylcholine Receptor Positive Myasthenia Gravis
Lia Costa, Carla Fernandes
Drugs and Drug Candidates (2024) Vol. 3, Iss. 2, pp. 311-327
Open Access | Times Cited: 2
Evaluation of the effectiveness of in-hospital exercise rehabilitation in middle-aged and elderly patients with type 2 diabetes mellitus combined with sarcopenia Effect of lifestyle management on disease status in patients with type 2 diabetes mellitus
Jianhua Shi, Gaojun Yin, Zhiyun Shi, et al.
Research Square (Research Square) (2024)
Open Access
Autoimmune Models
David M. Cauvi, Per Hultman, K. Michael Pollard
Elsevier eBooks (2024)
Closed Access
Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus
Jianhua Shi, Gaojun Yin, Zhiyun Shi, et al.
Endocrine Research (2024) Vol. 49, Iss. 3, pp. 154-164
Open Access
Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis
Carlo Antozzi, Renato Mantegazza
Patient Related Outcome Measures (2023) Vol. Volume 14, pp. 305-312
Open Access | Times Cited: 1
Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis
Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1756-1756
Open Access | Times Cited: 1
Assay Development and Measurement of Autoantibody-Mediated Complement Activity in Myasthenia Gravis
Abeer Obaid
RRNMF Neuromuscular Journal (2023) Vol. 4, Iss. 3
Open Access
Page 1

Scroll to top